RT Journal Article
SR Electronic
T1 Organophosphate and organohalogen flame-retardant exposure and thyroid hormone disruption in a cohort of female firefighters and office workers from San Francisco
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.06.20207498
DO 10.1101/2020.10.06.20207498
A1 Trowbridge, Jessica
A1 Gerona, Roy
A1 McMaster, Michael
A1 Ona, Catherine
A1 Clarity, Cassidy
A1 Bessonneau, Vincent
A1 Rudel, Ruthann
A1 Buren, Heather
A1 Morello-Frosch, Rachel
YR 2020
UL http://medrxiv.org/content/early/2020/10/07/2020.10.06.20207498.abstract
AB Background Occupational exposures to flame retardants (FR), which are suspected endocrine disrupting compounds, may be of particular concern for firefighters as they are commonly found in consumer products and have been detected in fire station dust and firefighter gear.Objectives The Women Workers Biomonitoring Collaborative is a community based participatory research study that sought to measure environmental chemicals relevant to firefighting and evaluate their effects on thyroid hormone levels.Methods We measured 10 FR or their metabolites in urine of female firefighters and office workers from San Francisco: bis(1,3-dichloro-2-propyl) phosphate (BDCPP), bis(2-chloroethyl) phosphate (BCEP), dibutyl phosphate (DBuP), dibenzyl phosphate (DBzP), di-p-cresyl phosphate (DpCP), di-o-cresyl phosphate (DoCP), 2,3,4,5-tetrabromobenzoic acid (TBBA), tetrabromobisphenol-A (TBBPA), 5-OH-BDE 47, and 5-OH-BDE 100. We assessed potential predictors of exposure levels and the association between FR exposures and thyroxine (T4) and thyroid stimulating hormone (TSH).Results BDCPP, BCEP, and DBuP were the most commonly detected FRs, among all study participants, with intermediate BMI and college educated women having the highest levels, and Black women having higher BDCPP levels than White women. Firefighters had higher detection frequencies (DF) and exposure levels compared to office workers; median BDCPP levels were five times higher in firefighters than in office workers. Among firefighters, occupational activities were not significantly associated with FR levels, although position (i.e. officer and firefighter versus driver), being on-duty (versus off-duty) and assigned to the airport suggested a positive association with FR levels. Among firefighters, a doubling of BDCPP was associated with a 2.88% decrease (95%CI −5.28,-0.42) in T4. We did not observe significant associations between FR and T4 among office workers.Discussion Firefighters had significantly higher exposures to FR compared to office workers, and we observed a negative association between BDCPP and thyroxine in firefighters. Future research should elucidate occupational sources of FR exposure and opportunities for exposure reduction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the California Breast Cancer Research Program #19BB-2900 and #23BB-1700 & 1701 & 1702 (JT, RG, CC, MM, CA, RAR, HB, VB, RMF), the National Institute of Environmental Health Sciences R01ES027051 (RMF), the National Institute for Occupational Safety and Health, Targeted Research Training Program T42 OH008429 (JT), the San Francisco Firefighter Cancer Prevention Foundation (HB) and the International Association of Firefighters-Local 798.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the University of California, Berkeley (# 2013-07-5512).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur IRB and human subjects protection precludes our ability to share data.